These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14631458)

  • 21. Treatment of cerebellar ataxia with buspirone: a double-blind study.
    Trouillas P; Xie J; Adeleine P
    Lancet; 1996 Sep; 348(9029):759. PubMed ID: 8806320
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of agitation in dementia patients].
    González Salvador MT; Arango López C; Lyketsos CG
    Med Clin (Barc); 1999 Nov; 113(15):592-7. PubMed ID: 10605687
    [No Abstract]   [Full Text] [Related]  

  • 23. Repurposing buspirone for drug addiction treatment.
    Le Foll B; Boileau I
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):251-3. PubMed ID: 23174122
    [No Abstract]   [Full Text] [Related]  

  • 24. Strategies for diagnosing and treating agitation in the aging.
    Barnes R; Raskind M
    Geriatrics; 1980 Mar; 35(3):111-9. PubMed ID: 6101569
    [No Abstract]   [Full Text] [Related]  

  • 25. 'The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia'--1997, 12, 519-527.
    Lawlor B
    Int J Geriatr Psychiatry; 1998 Jul; 13(7):496. PubMed ID: 9695043
    [No Abstract]   [Full Text] [Related]  

  • 26. Buspirone in primary headaches.
    Pascual J; Berciano J
    Acta Neurol Scand; 1998 Feb; 97(2):142. PubMed ID: 9517866
    [No Abstract]   [Full Text] [Related]  

  • 27. [Agitation].
    Fukatsu R; Akiyama H
    Nihon Rinsho; 2004 Apr; 62 Suppl 4():62-6. PubMed ID: 15174649
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
    Kudo T
    Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
    [No Abstract]   [Full Text] [Related]  

  • 29. Alternative treatment for poststroke depression.
    Mårtensson B; Murray V; von Arbin M; Asberg M; Bartfai A; Malm K
    Am J Psychiatry; 1997 Apr; 154(4):583-4. PubMed ID: 9090359
    [No Abstract]   [Full Text] [Related]  

  • 30. Buspirone in treatment of agitated demented patient.
    Colenda CC
    Lancet; 1988 May; 1(8595):1169. PubMed ID: 2896993
    [No Abstract]   [Full Text] [Related]  

  • 31. Agitation associated with dementia: a systematic approach to treatment.
    Leibovici A; Tariot PN
    Psychopharmacol Bull; 1988; 24(1):49-53. PubMed ID: 3290949
    [No Abstract]   [Full Text] [Related]  

  • 32. [Buspirone chlorhydrate in the treatment of cerebellar ataxia].
    Andrade-Filho AS; Passos-Almeida J; Andrade-Souza VM; Sena-Pereira LR
    Rev Neurol; 2002 Aug 16-31; 35(4):301-5. PubMed ID: 12235556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible role of buspirone hydrochloride in smoking cessation.
    Bevelaqua FA
    Chest; 1997 Nov; 112(5):1445-6. PubMed ID: 9367495
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacologic management of the symptoms of dementia.
    McDonald WM; Krishnan KR
    Am Fam Physician; 1990 Jul; 42(1):123-32. PubMed ID: 2195854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
    Zaraa AS
    Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
    [No Abstract]   [Full Text] [Related]  

  • 36. Antidepressants for agitation and psychosis in patients with dementia.
    Bui Q
    Am Fam Physician; 2012 Jan; 85(1):20-2. PubMed ID: 22230303
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study.
    Steinberg M; Corcoran C; Tschanz JT; Huber C; Welsh-Bohmer K; Norton MC; Zandi P; Breitner JC; Steffens DC; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):824-30. PubMed ID: 16955439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Machado-Joseph disease/spinocerebellar ataxia 3 responsive to buspirone.
    Friedman JH
    Mov Disord; 1997 Jul; 12(4):613-4. PubMed ID: 9251088
    [No Abstract]   [Full Text] [Related]  

  • 39. Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls.
    Malt EA; Olafsson S; Aakvaag A; Lund A; Ursin H
    J Affect Disord; 2003 Jun; 75(1):77-82. PubMed ID: 12781354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effective anxiolytic therapy with Buspirone. Focusing on modulation of the serotonin-neurotransmitter system].
    Nervenarzt; 1996 Oct; 67(10 Suppl Effektive):1-4. PubMed ID: 9402426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.